To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene VKORC1L1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
309 supporting clones for gene VKORC1L1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK304077 trachea .a 1 to 1541 1 to 1544 H173I N174H R175N H176R F177H ... tiling clone,   1544/1544
(100 %)
2 diff
(99.9 %id)
DC415937 trachea .a 1 to 487 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
CN345917 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 115 to 326 1 to 212       212/212
(100 %)
5 diff
(97.7 %id)
BI227188 Burkitt lymphoma, lymph .b 1 to 795 1 to 787 L52W W55G V56*     787/789
(99 %)
31 diff
(96.1 %id)
BE562210 Burkitt lymphoma, lymph .b 5 to 730 23 to 747 A2S A3R P4L V5L L6R ...     725/920
(78 %)
30 diff
(96.8 %id)
CR602129 Placenta Cot 25-normalized .b 9 to 1155 1 to 1147 exact     1147/1147
(100 %)
0 diff
(100 %id)
BX377434 Placenta Cot 25-normalized .b 9 to 872 1 to 871 V5X L7X V9X V11X Y20X ...     871/871
(100 %)
25 diff
(97.2 %id)
BC027734 Lymph, Burkitt lymphoma .b 12 to 1156 1 to 1145 exact tiling clone, available from MGC, AAA   1145/1145
(100 %)
0 diff
(100 %id)
NM_173517.3   .b 12 to 1159 1 to 1148 exact RefSeq,   1148/1148
(100 %)
1 diff
(100.0 %id)
CR747620 leiomyosarcoma, uterus .b 27 to 520 12 to 505       494/505
(97 %)
6 diff
(98.9 %id)
BQ440689 leiomyosarcoma, uterus .b 29 to 738 1 to 713 exact     713/914
(78 %)
19 diff
(98.0 %id)
BE872610 adenocarcinoma, colon .b 39 to 770 1 to 728 L73W G74V S75P I76F F77W ...     728/729
(99 %)
26 diff
(96.5 %id)
BE620274 large cell carcinoma, undifferentiated, lung .b 74 to 671 1 to 596 W167G K168S R169G Q170S L171C ...     596/597
(99 %)
3 diff
(99.5 %id)
BX647631 human skeletal muscle .b 79 to 4174 1 to 4096 S30P K79R available from DKFZ, AAA Possibly primed on the genome, locally A rich (20/23 A in genome downstream of last aligned base) 4096/4096
(100 %)
9 diff
(99.8 %id)
BX642969   .b 80 to 493 7 to 420       414/420
(98 %)
6 diff
(98.6 %id)
AY423045 Kidney .b 93 to 916 1 to 824 exact     824/824
(100 %)
0 diff
(100 %id)
DR001922 fetal brain .b 94 to 749 1 to 657 exact     657/657
(100 %)
7 diff
(99.0 %id)
DN989752 brain, whole brain .b 98 to 682 1 to 586 V144X T145H Y146V V147R L148A ...     586/586
(100 %)
6 diff
(99.0 %id)
AK289522 cerebellum .b 99 to 1795 1 to 1697 F138S     1697/1697
(100 %)
2 diff
(99.9 %id)
DA101218 cerebellum .b 100 to 697 2 to 599 V108X F138S capped   598/598
(100 %)
2 diff
(99.7 %id)
DB497580 hypothalamus .b 105 to 608 1 to 504       504/504
(100 %)
1 diff
(99.9 %id)
TI_154142240   .b 105 to 803 69 to 760 L131P L152P Q172E     692/773
(89 %)
30 diff
(96.2 %id)
EL735259 mixed .b 114 to 643 1 to 530       530/649
(81 %)
1 diff
(99.9 %id)
TI_1948217295   .b 114 to 643 130 to 659       530/799
(66 %)
9 diff
(98.9 %id)
TI_1948217616   .b 114 to 600 130 to 618       489/1484
(32 %)
22 diff
(98.6 %id)
TI_1948217923   .b 114 to 613 131 to 632       502/1446
(34 %)
26 diff
(98.3 %id)
BQ421975 embryonal carcinoma, cell line, testis .b 142 to 1016 1 to 883       883/888
(99 %)
15 diff
(98.4 %id)
AW405108 lymph .b 147 to 658 1 to 512       512/512
(100 %)
3 diff
(99.5 %id)
TI_1948217296   .b 165 to 643 610 to 130       481/1461
(32 %)
5 diff
(99.7 %id)
R47336   .b 167 to 490 1 to 324       324/324
(100 %)
7 diff
(97.9 %id)
BG824072 adenocarcinoma cell line, colon .b 167 to 929 1 to 767       767/769
(99 %)
24 diff
(96.9 %id)
DA236824 brain .b 205 to 751 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
TI_1948216955   .b 295 to 643 473 to 126       348/1319
(26 %)
6 diff
(99.6 %id)
TI_1948216956   .b 305 to 643 470 to 131       340/1427
(23 %)
6 diff
(99.6 %id)
BG183602   .b 308 to 442 1 to 135       135/135
(100 %)
2 diff
(98.6 %id)
TI_227714514   .b 311 to 1156 937 to 96   AAA   840/986
(85 %)
19 diff
(98.1 %id)
CR627471 melanoma (MeWo cell line) .b 324 to 5809 1 to 5487   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 5487/5487
(100 %)
2 diff
(100.0 %id)
DB526930 testis .b 347 to 803 1 to 458     Submitted on the opposite strand 458/460
(99 %)
3 diff
(99.4 %id)
AK124688 amygdala .b 359 to 3670 1 to 3312   available from FLJ,   3312/3312
(100 %)
7 diff
(99.8 %id)
DA185262 amygdala .b 360 to 911 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BE620808 large cell carcinoma, undifferentiated, lung .b 371 to 1021 662 to 1       662/665
(99 %)
27 diff
(96.0 %id)
BG197326   .b 418 to 561 1 to 144       144/144
(100 %)
4 diff
(97.3 %id)
BG215114   .b 419 to 853 442 to 9     Submitted on the opposite strand 434/442
(98 %)
0 diff
(100 %id)
AA327128 colon .b 431 to 553 1 to 123       123/123
(100 %)
1 diff
(99.2 %id)
BX351330 Placenta Cot 25-normalized .b 442 to 1152 718 to 1       718/718
(100 %)
0 diff
(100 %id)
TI_149301712   .b 444 to 1162 818 to 107   AAA   712/831
(85 %)
9 diff
(99.0 %id)
F32095 pectoral muscle (after mastectomy) .b 500 to 668 171 to 3       169/171
(98 %)
0 diff
(100 %id)
BM980034 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 500 to 1162 681 to 19   AAA   663/663
(100 %)
0 diff
(100 %id)
DA416380 thalamus .b 502 to 1056 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CD365104 Alveolar Macrophage, lung .b 518 to 1156 657 to 19   AAA   639/639
(100 %)
3 diff
(99.6 %id)
R60493 whole brain .b 561 to 1024 1 to 475       475/475
(100 %)
54 diff
(88.7 %id)
AI989511 pooled germ cell tumors .b 566 to 1055 493 to 4       490/493
(99 %)
0 diff
(100 %id)
DB568679 hypothalamus .b 570 to 1064 1 to 495     Submitted on the opposite strand 495/495
(100 %)
3 diff
(99.4 %id)
BY996169   .b 573 to 1157 623 to 39     Submitted on the opposite strand 585/623
(93 %)
0 diff
(100 %id)
CD368814 Alveolar Macrophage, lung .b 573 to 1162 608 to 19   AAA   590/590
(100 %)
1 diff
(99.9 %id)
AA343194 Spleen .b 576 to 880 1 to 305       305/308
(99 %)
6 diff
(98.1 %id)
AW966390   .b 576 to 1155 78 to 657       580/657
(88 %)
6 diff
(99.1 %id)
DB225504 trachea .b 601 to 1181 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
AI761553 colon, colon tumor, RER+ .b 604 to 1155 553 to 1       553/553
(100 %)
9 diff
(98.4 %id)
CD357974 Pooled-Skin .b 622 to 1156 1 to 535       535/817
(65 %)
1 diff
(99.9 %id)
BX389482 Placenta Cot 25-normalized .b 708 to 1155 1 to 452       452/452
(100 %)
10 diff
(97.8 %id)
DB229229 trachea .b 733 to 1320 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DA817898   .b 738 to 1283 26 to 571   capped   546/570
(95 %)
6 diff
(99.0 %id)
AI669310 Prostate .b 752 to 1156 405 to 1       405/405
(100 %)
0 diff
(100 %id)
BU153930 eye, retinoblastoma .b 755 to 1590 1 to 840       840/872
(96 %)
11 diff
(98.8 %id)
BU176273 eye, retinoblastoma .b 755 to 1618 1 to 875       875/881
(99 %)
14 diff
(98.5 %id)
BU197376 eye, retinoblastoma .b 755 to 1613 1 to 865       865/865
(100 %)
6 diff
(99.4 %id)
BE878879 large cell carcinoma, undifferentiated, lung .b 773 to 1505 1 to 720       720/930
(77 %)
17 diff
(98.2 %id)
DA198339 brain .b 911 to 1462 2 to 555   capped   554/555
(99 %)
3 diff
(99.5 %id)
DB165590 thymus .b 917 to 1509 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
CX871123 embryonic stem .b 939 to 1791 1 to 853       853/853
(100 %)
0 diff
(100 %id)
AK001747   .b 950 to 4178 1 to 3229   available from FLJ,   3229/3229
(100 %)
3 diff
(100.0 %id)
AU133379   .b 951 to 1686 2 to 739   capped   738/742
(99 %)
13 diff
(98.3 %id)
EC532809 Prostate .b 959 to 1058 1 to 100       100/100
(100 %)
0 diff
(100 %id)
BM837793 Ascites, stomach .b 976 to 1614 1 to 639       639/639
(100 %)
0 diff
(100 %id)
DB043895 testis .b 976 to 1550 2 to 577   capped   576/576
(100 %)
2 diff
(99.7 %id)
EC508668 Prostate .b 982 to 1077 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
DA332295 hippocampus .b 999 to 1591 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
AU131812   .b 1019 to 1755 2 to 744   capped   743/746
(99 %)
15 diff
(98.0 %id)
AL137548 testis .b 1127 to 4889 1 to 3763   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 3763/3763
(100 %)
0 diff
(100 %id)
BF436045 pooled .b 1170 to 1731 562 to 1       562/562
(100 %)
0 diff
(100 %id)
DA451307 tongue, tumor tissue .b 1188 to 1751 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
AU132175   .b 1311 to 2114 2 to 800   capped   799/799
(100 %)
8 diff
(99.0 %id)
AU123616   .b 1315 to 1840 2 to 526   capped   525/525
(100 %)
3 diff
(99.5 %id)
DB070597 testis .b 1326 to 1867 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
CN393484 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1331 to 1860 1 to 530       530/530
(100 %)
0 diff
(100 %id)
BE075233 breast .b 1350 to 1938 597 to 9     Submitted on the opposite strand 589/623
(94 %)
0 diff
(100 %id)
BE075231 breast .b 1356 to 1930 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
BG036042 adenocarcinoma, cell line, Liver .b 1364 to 2134 1 to 763       763/1046
(72 %)
24 diff
(97.8 %id)
CU443845 epidermis .b 1383 to 1929 10 to 557       548/561
(97 %)
9 diff
(98.4 %id)
DA767171 tongue .b 1403 to 1995 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
CD642388 Embryonic Stem cells .b 1420 to 2160 43 to 780       738/865
(85 %)
6 diff
(99.4 %id)
BG325076 Kidney, renal cell adenocarcinoma .b 1421 to 2245 1 to 844       844/848
(99 %)
35 diff
(95.9 %id)
AA355620   .b 1459 to 1723 1 to 266       266/269
(98 %)
3 diff
(98.9 %id)
DA548320   .b 1481 to 2045 2 to 562   capped   561/561
(100 %)
6 diff
(99.0 %id)
BG170419 hypernephroma, cell line, Kidney .b 1532 to 2291 1 to 747       747/952
(78 %)
34 diff
(96.5 %id)
BM837204 Ascites, stomach .b 1559 to 2148 1 to 590       590/590
(100 %)
0 diff
(100 %id)
DB078298 testis .b 1572 to 2131 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA091293 cerebellum .b 1574 to 2034 2 to 463   capped   462/462
(100 %)
1 diff
(99.8 %id)
DA935753 Spleen .b 1574 to 2171 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
AA101376 brain, neuroepithelial cells .b 1585 to 1957 1 to 375       375/375
(100 %)
2 diff
(99.5 %id)
AU131197   .b 1589 to 2436 2 to 854   capped   853/853
(100 %)
10 diff
(98.9 %id)
AU133775 ovary, tumor tissue .b 1625 to 2368 2 to 747   capped   746/746
(100 %)
6 diff
(99.2 %id)
AA316575 colon .b 1626 to 2078 1 to 452       452/452
(100 %)
3 diff
(99.4 %id)
DA784800 brain .b 1626 to 2205 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
BX504238   .b 1630 to 2177 1 to 549       549/549
(100 %)
2 diff
(99.7 %id)
CN393487 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1639 to 2351 1 to 714       714/714
(100 %)
3 diff
(99.6 %id)
BG216244   .b 1666 to 2393 777 to 53     Submitted on the opposite strand 725/782
(92 %)
0 diff
(100 %id)
CN393486 embryonic stem cells, DMSO-treated H9 cellline .b 1675 to 2011 1 to 337       337/337
(100 %)
0 diff
(100 %id)
BE813315 breast_normal .b 1676 to 2232 1 to 560       560/560
(100 %)
7 diff
(98.8 %id)
BQ028241 mixed .b 1685 to 2156 1 to 472     Submitted on the opposite strand 472/472
(100 %)
4 diff
(99.2 %id)
CA435140 lung, Lung Focal Fibrosis .b 1685 to 2251 1 to 567     Submitted on the opposite strand 567/567
(100 %)
5 diff
(99.2 %id)
DA580605   .b 1690 to 2266 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BX498654 Liver .b 1706 to 2106 1 to 401       401/401
(100 %)
7 diff
(98.3 %id)
BM045663 carcinoma, cell line, Prostate .b 1707 to 2400 1 to 692       692/701
(98 %)
9 diff
(98.8 %id)
BM047473 carcinoma, cell line, Prostate .b 1707 to 2497 1 to 786       786/786
(100 %)
10 diff
(98.8 %id)
DA804187 brain .b 1707 to 2248 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB077564 testis .b 1707 to 2275 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA871884 Prostate .b 1716 to 2259 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DA143861 amygdala .b 1720 to 2223 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
DA584708 lung .b 1720 to 2314 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA169557 amygdala .b 1721 to 2284 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB096648 testis .b 1721 to 2273 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA149487 amygdala .b 1724 to 2303 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
AU134373 ovary, tumor tissue .b 1725 to 2459 2 to 735   capped   734/739
(99 %)
5 diff
(99.4 %id)
DA687548   .b 1743 to 2287 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
N40641 melanocyte .b 1775 to 2214 1 to 446       446/446
(100 %)
8 diff
(98.3 %id)
BG004445 placenta_normal .b 1790 to 2386 18 to 612       595/613
(97 %)
34 diff
(94.5 %id)
CN393485 embryonic stem cells, DMSO-treated H9 cellline .b 1813 to 2411 1 to 599       599/599
(100 %)
0 diff
(100 %id)
CB146867 Liver .b 1824 to 2378 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
BM710897 eye, fetal eyes .b 1833 to 2286 10 to 463   fully sequenced,   454/463
(98 %)
0 diff
(100 %id)
BG112687 Bone, osteosarcoma, cell line .b 1846 to 2580 13 to 742       730/965
(75 %)
14 diff
(98.6 %id)
DA543990   .b 1856 to 2423 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AK000750   .b 1865 to 3828 1 to 1964   available from FLJ,   1964/1964
(100 %)
0 diff
(100 %id)
BG283233 adenocarcinoma, cell line, Prostate .b 1876 to 2151 1 to 273       273/273
(100 %)
3 diff
(99.0 %id)
BU542098 carcinoma, cell line, Prostate .b 1876 to 2680 1 to 812       812/916
(88 %)
12 diff
(98.7 %id)
CB161001 Liver .b 1878 to 2463 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BM459298 lymph, lymphoma, cell line .b 1921 to 2762 1 to 852       852/1070
(79 %)
21 diff
(98.1 %id)
BG488974 large cell carcinoma, lung .b 1932 to 2532 1 to 617       617/864
(71 %)
43 diff
(95.1 %id)
CN393488 embryonic stem cells, cell lines H1, H7, andH9 .b 1945 to 2527 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
DA754046   .b 1963 to 2266 2 to 305   capped   304/304
(100 %)
0 diff
(100 %id)
AU126934   .b 1977 to 2667 2 to 693   capped   692/695
(99 %)
10 diff
(98.6 %id)
AU117415 whole embryo, mainly head .b 1981 to 2714 2 to 734   capped   733/733
(100 %)
3 diff
(99.6 %id)
DA596569   .b 1981 to 2533 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA230750 brain .b 1993 to 2561 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA696708   .b 1994 to 2561 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA200457 brain .b 1995 to 2567 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
TI_154129603   .b 2031 to 2905 957 to 103   AAA   855/976
(87 %)
60 diff
(93.9 %id)
BI225022 Burkitt lymphoma, lymph .b 2052 to 2637 1 to 585       585/587
(99 %)
4 diff
(99.4 %id)
BI226665 Burkitt lymphoma, lymph .b 2053 to 2812 1 to 757       757/757
(100 %)
13 diff
(98.3 %id)
BE397506 Burkitt lymphoma, lymph .b 2054 to 2729 37 to 707       671/792
(84 %)
15 diff
(98.2 %id)
BE560796 Burkitt lymphoma, lymph .b 2073 to 2808 1 to 731       731/807
(90 %)
15 diff
(98.2 %id)
AA029103 uterus .b 2087 to 2517 1 to 433       433/433
(100 %)
3 diff
(99.4 %id)
BX107491 uterus .b 2088 to 2866 1 to 781       781/781
(100 %)
2 diff
(99.8 %id)
C05944   .b 2088 to 2503 424 to 8       417/430
(96 %)
0 diff
(100 %id)
BQ231892 embryonal carcinoma, cell line, testis .b 2089 to 2750 1 to 669       669/911
(73 %)
27 diff
(97.1 %id)
DB191908 ovary, tumor tissue .b 2091 to 2624 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
AA081649   .b 2100 to 2413 1 to 317       317/317
(100 %)
3 diff
(99.1 %id)
N40015 placenta .b 2126 to 2518 1 to 395   fully sequenced,   395/395
(100 %)
3 diff
(99.3 %id)
DA684549   .b 2127 to 2657 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
AU120935 whole embryo, mainly body .b 2148 to 2908 2 to 761   capped   760/760
(100 %)
4 diff
(99.5 %id)
BF527840 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2162 to 2925 1 to 758       758/758
(100 %)
15 diff
(98.1 %id)
AA808087 germinal center B cell .b 2201 to 2502 324 to 23   AAA   302/302
(100 %)
0 diff
(100 %id)
BG779401 adenocarcinoma, Prostate .b 2206 to 2879 1 to 687       687/726
(94 %)
41 diff
(94.4 %id)
BM743236 stomach .b 2210 to 2790 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BM744940 stomach .b 2210 to 2820 1 to 611       611/611
(100 %)
2 diff
(99.7 %id)
BM744964 stomach .b 2210 to 2666 1 to 457       457/457
(100 %)
1 diff
(99.8 %id)
BM772348 stomach .b 2210 to 2851 1 to 642       642/642
(100 %)
0 diff
(100 %id)
BM772382 stomach .b 2210 to 2803 1 to 594       594/594
(100 %)
0 diff
(100 %id)
BM744696 stomach .b 2211 to 2596 1 to 386       386/386
(100 %)
3 diff
(99.3 %id)
CD369950 Alveolar Macrophage, lung .b 2246 to 2905 677 to 19   AAA   659/659
(100 %)
1 diff
(99.9 %id)
BM665990 eye, fetal eyes .b 2256 to 2905 666 to 17   fully sequenced, AAA   650/650
(100 %)
0 diff
(100 %id)
FN175787 breast carcinoma .b 2259 to 2363 105 to 1     Submitted on the opposite strand 105/105
(100 %)
0 diff
(100 %id)
AA056419 colon, tumor .b 2289 to 2756 484 to 1       484/496
(97 %)
15 diff
(97.0 %id)
DA126878 cerebellum .b 2370 to 2955 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA649441   .b 2371 to 2895 2 to 527   capped   526/526
(100 %)
2 diff
(99.7 %id)
AI432185 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2374 to 2905 532 to 1       532/532
(100 %)
0 diff
(100 %id)
F11699 brain, total brain .b 2376 to 2745 1 to 370       370/370
(100 %)
0 diff
(100 %id)
BE898125 melanotic melanoma, skin .b 2384 to 3177 1 to 794       794/825
(96 %)
25 diff
(97.0 %id)
AA577619 colon, colon tumor .b 2407 to 2908 513 to 12   AAA   502/502
(100 %)
0 diff
(100 %id)
CD517865 White Matter .b 2409 to 2993 1 to 594       594/1095
(54 %)
15 diff
(98.7 %id)
EC482920 Prostate .b 2411 to 2513 1 to 102       102/102
(100 %)
1 diff
(99.1 %id)
BQ015671 placenta .b 2433 to 2905 490 to 18   AAA   473/473
(100 %)
1 diff
(99.8 %id)
AI813627 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 2449 to 2895 457 to 11       447/457
(97 %)
0 diff
(100 %id)
N27281 placenta .b 2488 to 2906 423 to 1   fully sequenced,   423/423
(100 %)
2 diff
(99.6 %id)
AI522190 Kidney .b 2498 to 2773 311 to 36   AAA   276/276
(100 %)
8 diff
(97.2 %id)
EC518984 Prostate .b 2533 to 2602 1 to 71       71/84
(84 %)
2 diff
(97.7 %id)
AA306581   .b 2587 to 3006 1 to 418       418/428
(97 %)
3 diff
(99.3 %id)
AA029993 uterus .b 2593 to 2903 329 to 4       326/332
(98 %)
0 diff
(100 %id)
DA750933   .b 2619 to 3183 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AW958814   .b 2622 to 3250 1 to 627       627/631
(99 %)
31 diff
(95.1 %id)
DA483800 brain .b 2651 to 3104 2 to 455   capped   454/454
(100 %)
0 diff
(100 %id)
BG697653 skin .b 2686 to 3327 1 to 647       647/647
(100 %)
11 diff
(98.3 %id)
BX646648   .b 2721 to 3298 1 to 578       578/578
(100 %)
0 diff
(100 %id)
BX500933 Liver .b 2739 to 3310 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
BE865744 bladder, carcinoma, cell line .b 2759 to 3442 1 to 677       677/829
(81 %)
25 diff
(97.0 %id)
BE868330 adenocarcinoma, colon .b 2803 to 3521 1 to 713       713/845
(84 %)
29 diff
(96.6 %id)
DR761300 embryonic stem .b 2828 to 3501 1 to 674       674/674
(100 %)
3 diff
(99.6 %id)
DA358704 subthalamic nucleus .b 2844 to 3411 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
BF700437 brain, primitive neuroectoderm .b 2888 to 3503 1 to 613       613/613
(100 %)
9 diff
(98.6 %id)
T26491   .b 2951 to 3268 1 to 319       319/320
(99 %)
22 diff
(93.2 %id)
BG177405 lymph, lymphoma, cell line .b 2975 to 3758 11 to 793       783/989
(79 %)
37 diff
(96.3 %id)
BM460234 eye, retinoblastoma .b 2987 to 3911 28 to 952       925/1056
(87 %)
26 diff
(97.6 %id)
CN402344 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3019 to 3668 1 to 651       651/651
(100 %)
2 diff
(99.7 %id)
AA248474   .b 3104 to 3321 1 to 216       216/216
(100 %)
4 diff
(98.2 %id)
DB303121 amygdala .b 3120 to 3670 551 to 1       551/551
(100 %)
6 diff
(99.0 %id)
TI_154164986   .b 3159 to 3829 71 to 739   AAA   669/882
(75 %)
23 diff
(97.4 %id)
CF136121 lymph .b 3160 to 3624 9 to 472       464/472
(98 %)
1 diff
(99.8 %id)
AW104831 ovary, tumor, 5 pooled (see description) .b 3213 to 3662 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
AI858057 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 3228 to 3825 599 to 1       599/599
(100 %)
2 diff
(99.7 %id)
BG290643 bladder, transitional cell papilloma, cell line .b 3229 to 3980 1 to 748       748/765
(97 %)
30 diff
(96.1 %id)
BG939582 bone marrow stroma .b 3235 to 3848 636 to 23       614/636
(96 %)
0 diff
(100 %id)
W47190 senescent fibroblast .b 3239 to 3614 1 to 378       378/378
(100 %)
2 diff
(99.5 %id)
AU155385 ovary, tumor tissue .b 3265 to 3826 565 to 1       565/571
(98 %)
11 diff
(98.1 %id)
DA530380 brain .b 3266 to 3874 2 to 610   capped   609/609
(100 %)
6 diff
(99.1 %id)
DB368850   .b 3268 to 3828 565 to 2       564/565
(99 %)
0 diff
(100 %id)
AU154979 ovary, tumor tissue .b 3273 to 3827 554 to 1       554/555
(99 %)
12 diff
(97.9 %id)
DA884008   .b 3282 to 3828 2 to 548   capped, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 547/547
(100 %)
0 diff
(100 %id)
DA706406   .b 3283 to 3838 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
AI888298 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3356 to 3826 472 to 2       471/472
(99 %)
0 diff
(100 %id)
AI279477 carcinoid, lung .b 3358 to 3825 467 to 1       467/483
(96 %)
7 diff
(98.6 %id)
AA425406   .b 3380 to 3779 448 to 50       399/448
(89 %)
0 diff
(100 %id)
BX478243   .b 3420 to 3939 1 to 521       521/521
(100 %)
5 diff
(99.1 %id)
BC007465 Kidney, hypernephroma .b 3446 to 4889 1 to 1442   available from MGC, AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 1442/1442
(100 %)
6 diff
(99.6 %id)
AL527073 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 3454 to 4290 64 to 899       836/899
(92 %)
6 diff
(99.4 %id)
BF031011 hypernephroma, Kidney .b 3466 to 4193 1 to 729   available from MGC,   729/796
(91 %)
53 diff
(93.4 %id)
BG163541 hypernephroma, cell line, Kidney .b 3477 to 4180 1 to 699       699/958
(72 %)
17 diff
(98.3 %id)
F09357 brain, total brain .b 3491 to 3826 336 to 1       336/336
(100 %)
3 diff
(99.2 %id)
BG324655 Kidney, renal cell adenocarcinoma .b 3491 to 3606 636 to 752       709/768
(92 %)
41 diff
(94.7 %id)
AU130725   .b 3512 to 4252 2 to 743   capped   742/742
(100 %)
8 diff
(99.0 %id)
BE207261 lung, small cell carcinoma .b 3515 to 3931 1 to 419   fully sequenced, AAA   419/419
(100 %)
6 diff
(98.6 %id)
DA606264   .b 3522 to 4055 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
BG497568 adenocarcinoma, Prostate .b 3550 to 4350 1 to 816       816/838
(97 %)
45 diff
(94.7 %id)
BG777851 adenocarcinoma, Prostate .b 3550 to 4197 1 to 657       657/680
(96 %)
21 diff
(97.0 %id)
AW249151 lung, small cell carcinoma .b 3602 to 4022 129 to 551   fully sequenced,   423/551
(76 %)
6 diff
(99.0 %id)
BF031884 hypernephroma, Kidney .b 3629 to 4184 1 to 564       564/569
(99 %)
26 diff
(95.5 %id)
AU154726   .b 3641 to 4178 534 to 1       534/553
(96 %)
11 diff
(98.1 %id)
DB363705   .b 3659 to 4178 520 to 1       520/534
(97 %)
27 diff
(95.0 %id)
DB368278   .b 3666 to 4192 515 to 1       515/533
(96 %)
24 diff
(95.5 %id)
DB355217 whole embryo, mainly head .b 3672 to 4125 511 to 55       457/513
(89 %)
0 diff
(100 %id)
DB369179   .b 3672 to 4192 520 to 1       520/523
(99 %)
11 diff
(97.9 %id)
BE779558 eye, retinoblastoma .b 3732 to 4404 1 to 682       682/1012
(67 %)
41 diff
(96.0 %id)
BF676380 Prostate .b 3740 to 4408 1 to 679       679/688
(98 %)
23 diff
(96.7 %id)
AI445659 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3765 to 4178 414 to 1       414/414
(100 %)
5 diff
(98.8 %id)
AA101377 brain, neuroepithelial cells .b 3768 to 4180 416 to 1       416/416
(100 %)
3 diff
(99.3 %id)
W47141 senescent fibroblast .b 3777 to 4200 427 to 4       424/429
(98 %)
0 diff
(100 %id)
AA084679   .b 3820 to 4177 359 to 1       359/365
(98 %)
1 diff
(99.8 %id)
AA219542 brain, neuroepithelial cells .b 3832 to 4166 335 to 1       335/335
(100 %)
0 diff
(100 %id)
AA776548   .b 3853 to 4175 343 to 22     Submitted on the opposite strand 322/343
(93 %)
0 diff
(100 %id)
AA679173   .b 3860 to 4178 319 to 1       319/319
(100 %)
2 diff
(99.4 %id)
AW615724 lung, small cell carcinoma .b 3901 to 4181 283 to 1   fully sequenced,   283/283
(100 %)
1 diff
(99.7 %id)
BE564399 bladder, carcinoma, cell line .b 3929 to 4484 1 to 556       556/556
(100 %)
5 diff
(99.2 %id)
CD512009 Pooled-Skin .b 3932 to 4644 4 to 728       725/824
(87 %)
23 diff
(97.3 %id)
AL527032 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 3967 to 4858 896 to 1       896/896
(100 %)
12 diff
(98.7 %id)
AW248724 lung, small cell carcinoma .b 3992 to 4188 199 to 1   fully sequenced,   199/199
(100 %)
2 diff
(99.0 %id)
BE531009 adenocarcinoma, Pancreas .b 4093 to 4751 1 to 658       658/658
(100 %)
1 diff
(99.9 %id)
AA385237 thyroid gland .b 4144 to 4322 1 to 179       179/179
(100 %)
2 diff
(98.9 %id)
AW966610   .b 4145 to 4705 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
R57534   .b 4149 to 4469 1 to 316       316/328
(96 %)
10 diff
(97.0 %id)
BI495824 cochlea, ear .b 4174 to 4825 700 to 49   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 652/652
(100 %)
4 diff
(99.4 %id)
DA586223 lung .b 4176 to 4775 2 to 601   capped   600/600
(100 %)
1 diff
(99.9 %id)
BX409687.
matches multiple genes
brain, neuroblastoma, neuroblastoma cells .b 4180 to 4892 1 to 709     also hits gene DR1 709/709
(100 %)
8 diff
(98.9 %id)
DA730554   .b 4228 to 4916 169 to 851   capped   683/851
(80 %)
18 diff
(97.9 %id)
AW451494   .b 4311 to 4889 596 to 18   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
AA024797 heart .b 4375 to 4694 1 to 323   fully sequenced,   323/323
(100 %)
1 diff
(99.7 %id)
BF983219 duodenal adenocarcinoma, cell line, small intestine .b 4376 to 5049 1 to 676       676/678
(99 %)
5 diff
(99.3 %id)
AV724827 hypothalamus .b 4379 to 4885 1 to 503       503/701
(71 %)
8 diff
(98.9 %id)
AV724964 hypothalamus .b 4379 to 4864 1 to 486       486/494
(98 %)
1 diff
(99.8 %id)
AA628901   .b 4390 to 4892 506 to 4       503/506
(99 %)
0 diff
(100 %id)
AA918969 2 pooled tumors (clear cell type), Kidney .b 4393 to 4892 504 to 5       500/509
(98 %)
0 diff
(100 %id)
AI580070 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4399 to 4889 491 to 1       491/491
(100 %)
0 diff
(100 %id)
BM993197 lung, Metastatic Chondrosarcoma .b 4399 to 4889 509 to 19   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 491/491
(100 %)
1 diff
(99.8 %id)
BF061817 pooled germ cell tumors .b 4401 to 4889 490 to 2       489/490
(99 %)
0 diff
(100 %id)
AA357391 Prostate .b 4405 to 4821 1 to 418       418/419
(99 %)
6 diff
(98.6 %id)
AA357806 Prostate .b 4405 to 4705 1 to 301       301/301
(100 %)
0 diff
(100 %id)
AA024724 heart .b 4417 to 4612 1 to 196   fully sequenced,   196/196
(100 %)
0 diff
(100 %id)
CF145097 CNCAP(3)T-225 cell line, Prostate .b 4420 to 4876 1 to 457       457/457
(100 %)
5 diff
(99.0 %id)
CF145177 CNCAP(3)T-225 cell line, Prostate .b 4420 to 4796 1 to 377       377/377
(100 %)
6 diff
(98.5 %id)
CF123000 CNCAP(3)T-225 cell line, Prostate .b 4420 to 5019 1 to 600       600/600
(100 %)
11 diff
(98.2 %id)
AI332965 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4421 to 4892 473 to 2       472/473
(99 %)
0 diff
(100 %id)
AI769876 2 pooled tumors (clear cell type), Kidney .b 4422 to 4892 472 to 2       471/472
(99 %)
0 diff
(100 %id)
TI_154177257   .b 4427 to 4964 80 to 617       538/540
(99 %)
3 diff
(99.5 %id)
TI_154177353   .b 4427 to 4957 80 to 615       536/683
(78 %)
24 diff
(96.5 %id)
TI_154182744   .b 4427 to 5082 77 to 732       656/894
(73 %)
19 diff
(97.9 %id)
AW955285   .b 4432 to 5071 1 to 641       641/641
(100 %)
3 diff
(99.6 %id)
BE503459 pooled germ cell tumors .b 4433 to 4889 458 to 2       457/458
(99 %)
0 diff
(100 %id)
AI656218 pooled germ cell tumors .b 4443 to 4892 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
CX761983 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 4459 to 5191 16 to 748     Submitted on the opposite strand 733/748
(97 %)
6 diff
(99.2 %id)
N22206 cochlea, ear .b 4499 to 4892 401 to 4       398/403
(98 %)
0 diff
(100 %id)
F30756 pectoral muscle (after mastectomy) .b 4500 to 4825 1 to 324       324/324
(100 %)
5 diff
(98.5 %id)
F37272 pectoral muscle (after mastectomy) .b 4500 to 4750 1 to 250       250/250
(100 %)
1 diff
(99.6 %id)
AI635151 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 4516 to 4889 402 to 29   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
AI913847 colon .b 4517 to 4888 378 to 4       375/378
(99 %)
0 diff
(100 %id)
AI091971 parathyroid gland, parathyroid tumor .b 4524 to 4730 207 to 1       207/207
(100 %)
1 diff
(99.6 %id)
AI332884 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4531 to 4889 372 to 14   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 359/359
(100 %)
2 diff
(99.5 %id)
AW627981 pooled .b 4531 to 4890 360 to 1       360/360
(100 %)
0 diff
(100 %id)
BF437507 Prostate .b 4540 to 4884 345 to 1       345/345
(100 %)
14 diff
(96.0 %id)
AW274582 pooled .b 4558 to 4889 332 to 1       332/332
(100 %)
0 diff
(100 %id)
AW572782 pooled .b 4558 to 4889 332 to 1       332/332
(100 %)
0 diff
(100 %id)
AA024449 heart .b 4570 to 4892 323 to 1       323/325
(99 %)
1 diff
(99.7 %id)
AA024706 heart .b 4582 to 4892 316 to 1   fully sequenced,   316/316
(100 %)
6 diff
(98.2 %id)
AI027371 parathyroid gland, parathyroid tumor .b 4582 to 4892 320 to 5       316/320
(98 %)
0 diff
(100 %id)
AW572957 pooled .b 4630 to 4890 261 to 1       261/261
(100 %)
0 diff
(100 %id)
AA653258   .b 4655 to 4890 268 to 33   AAA Possibly primed on the genome, locally A rich (17/19 A in genome downstream of last aligned base) 236/236
(100 %)
2 diff
(99.2 %id)
CR743167 liver and spleen .b 4661 to 5446 1 to 787       787/787
(100 %)
2 diff
(99.8 %id)
AA024445 heart .b 4664 to 4892 230 to 1   fully sequenced,   230/230
(100 %)
0 diff
(100 %id)
CB116068 Liver .b 4677 to 5250 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
BG025149 lymph, lymphoma, cell line .b 4801 to 5398 1 to 601       601/601
(100 %)
8 diff
(98.7 %id)
N31765 melanocyte .b 4933 to 5309 1 to 383   fully sequenced,   383/383
(100 %)
2 diff
(99.5 %id)
N57438 placenta .b 4981 to 5408 1 to 442       442/512
(86 %)
18 diff
(96.5 %id)
BM458735 lymph, lymphoma, cell line .b 5061 to 5842 1 to 781   tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 781/781
(100 %)
4 diff
(99.5 %id)
BI115438 muscle, rhabdomyosarcoma .b 5092 to 5511 1 to 426       426/1120
(38 %)
14 diff
(98.8 %id)
BF037219 adenocarcinoma, ovary .b 5139 to 5887 1 to 736       736/816
(90 %)
20 diff
(97.6 %id)
AA633413   .b 5149 to 5429 493 to 212       282/497
(56 %)
0 diff
(100 %id)
AI086578 senescent fibroblast .b 5158 to 5721 571 to 8       564/571
(98 %)
0 diff
(100 %id)
BQ004839 Chondrosarcoma, Left Pelvis .b 5201 to 5900 709 to 14   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 696/696
(100 %)
9 diff
(98.8 %id)
BM472791 duodenal adenocarcinoma, cell line, small intestine .b 5253 to 5772 21 to 541       521/1165
(44 %)
24 diff
(98.0 %id)
N24836 melanocyte .b 5279 to 5648 373 to 1   fully sequenced,   373/373
(100 %)
3 diff
(99.2 %id)
DB367069   .b 5296 to 5837 536 to 1       536/536
(100 %)
20 diff
(96.3 %id)
DB362436   .b 5330 to 5900 568 to 1   tiling clone,   568/570
(99 %)
11 diff
(98.1 %id)
DB367873   .b 5356 to 5900 541 to 1       541/541
(100 %)
10 diff
(98.2 %id)
AW516207 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 5447 to 5839 399 to 7       393/399
(98 %)
0 diff
(100 %id)
BM991935 Bone, Subchondral Bone .b 5544 to 5906 381 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 363/364
(99 %)
19 diff
(94.8 %id)
N57917 liver and spleen .b 5556 to 5900 351 to 1       351/352
(99 %)
7 diff
(98.1 %id)
BG422392 Kidney, renal cell adenocarcinoma .b 5580 to 6298 1 to 737   tiling clone,   737/964
(76 %)
71 diff
(92.7 %id)
DB359806 whole embryo, mainly body .b 5600 to 5900 301 to 1       301/301
(100 %)
3 diff
(99.1 %id)
N29497 placenta .b 5636 to 5890 268 to 13       256/268
(95 %)
0 diff
(100 %id)
CX867310 embryonic stem .b 5642 to 5900 291 to 34     Submitted on the opposite strand 258/291
(88 %)
0 diff
(100 %id)
F22206 pectoral muscle (after mastectomy) .b 5658 to 5882 1 to 225       225/225
(100 %)
6 diff
(97.4 %id)
BG183321   .c 1 to 238 3 to 240 G7C H28P V67A tiling clone,   240/240
(100 %)
4 diff
(98.4 %id)
CN345916 embryonic stem cells, DMSO-treated H9 cellline .d-u 1 to 288 1 to 288 exact tiling clone,   288/288
(100 %)
0 diff
(100 %id)
DB357070 whole embryo, mainly head Gene VKORC1L1, variant not shown         Suspected internal deletion, this clone was ignored    
DA570311 whole embryo, mainly head Gene VKORC1L1, variant not shown       capped Suspected internal deletion, this clone was ignored    
BG207256   Gene VKORC1L1, variant not shown         Suspected internal deletion, suspected internal deletion, suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored    
BM465352 eye, retinoblastoma Gene VKORC1L1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC